
Now that Enliven Therapeutics Inc’s volume has hit 0.9 million, investors get a glimpse of its size.
Enliven Therapeutics Inc (NASDAQ: ELVN) on Tuesday, plunged -5.87% from the previous trading day, before settling in for the closing price of $23.0. Within the